Literature DB >> 24769887

False-positive rates associated with the use of multiple performance and symptom validity tests.

Glenn J Larrabee1.   

Abstract

Performance validity test (PVT) error rates using Monte Carlo simulation reported by Berthelson and colleagues (in False positive diagnosis of malingering due to the use of multiple effort tests. Brain Injury, 27, 909-916, 2013) were compared with PVT and symptom validity test (SVT) failure rates in two nonmalingering clinical samples. At a per-test false-positive rate of 10%, Monte Carlo simulation overestimated error rates for: (i) failure of ≥2 out of 5 PVTs/SVT for Larrabee (in Detection of malingering using atypical performance patterns on standard neuropsychological tests. The Clinical Neuropsychologist, 17, 410-425, 2003) and ACS (Pearson, Advanced clinical solutions for use with WAIS-IV and WMS-IV. San Antonio: Pearson Education, 2009) and (ii) failure of ≥2 out of 7 PVTs/SVT for Larrabee (Detection of malingering using atypical performance patterns on standard neuropsychological tests. The Clinical Neuropsychologist, 17, 410-425, 2003; Malingering scales for the Continuous Recognition Memory Test and Continuous Visual Memory Test. The Clinical Neuropsychologist, 23, 167-180, 2009 combined). Monte Carlo overestimation is likely because PVT performances are atypical in pattern or degree for what occurs in actual neurologic, psychiatric, or developmental disorders. Consequently, PVT scores form skewed distributions with performance at ceiling and restricted range, rather than forming a standard normal distribution with mean of 0 and standard deviation of 1.0. These results support the practice of using ≥2 PVT/SVT failures as representing probable invalid clinical presentation.
© The Author 2014. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Assessment; Forensic neuropsychology; Malingering/symptom validity testing

Mesh:

Year:  2014        PMID: 24769887     DOI: 10.1093/arclin/acu019

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  14 in total

Review 1.  Test validity and performance validity: considerations in providing a framework for development of an ability-focused neuropsychological test battery.

Authors:  Glenn J Larrabee
Journal:  Arch Clin Neuropsychol       Date:  2014-10-03       Impact factor: 2.813

2.  The dangers of failing one or more performance validity tests in individuals claiming mild traumatic brain injury-related postconcussive symptoms.

Authors:  Daniel A Proto; Nicholas J Pastorek; Brian I Miller; Jennifer M Romesser; Anita H Sim; John F Linck
Journal:  Arch Clin Neuropsychol       Date:  2014-09-24       Impact factor: 2.813

3.  Cumulative false positive rates given multiple performance validity tests: commentary on Davis and Millis (2014) and Larrabee (2014).

Authors:  Robert M Bilder; Catherine A Sugar; Gerhard S Hellemann
Journal:  Clin Neuropsychol       Date:  2014-12-10       Impact factor: 3.535

4.  A comparison of the self-report patterns of analog versus real-world malingerers of attention deficit hyperactivity disorder.

Authors:  Allyson G Harrison; Irene T Armstrong
Journal:  J Neural Transm (Vienna)       Date:  2020-11-05       Impact factor: 3.575

5.  A Meta-Analysis of Neuropsychological Effort Test Performance in Psychotic Disorders.

Authors:  Ivan Ruiz; Ian M Raugh; Lisa A Bartolomeo; Gregory P Strauss
Journal:  Neuropsychol Rev       Date:  2020-08-07       Impact factor: 7.444

6.  Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered.

Authors:  Jeremy J Davis
Journal:  J Clin Exp Neuropsychol       Date:  2018-05-20       Impact factor: 2.475

7.  Montreal Cognitive Assessment as a screening tool: Influence of performance and symptom validity.

Authors:  Brigid Waldron-Perrine; Nicolette M Gabel; Katharine Seagly; A Zarina Kraal; Percival Pangilinan; Robert J Spencer; Linas Bieliauskas
Journal:  Neurol Clin Pract       Date:  2019-04

8.  [Response distortion or symptom severity? Symptom description by psychiatric patients and sociomedical assessment subjects].

Authors:  Maximilian Wertz; Eva Mader; Norbert Nedopil; Kolja Schiltz; Elena Yundina
Journal:  Nervenarzt       Date:  2020-12-18       Impact factor: 1.214

Review 9.  Fibromyalgia and disability adjudication: no simple solutions to a complex problem.

Authors:  Manfred Harth; Warren R Nielson
Journal:  Pain Res Manag       Date:  2014 Nov-Dec       Impact factor: 3.037

10.  Replication and cross-validation of the personality assessment inventory (PAI) cognitive bias scale (CBS) in a mixed clinical sample.

Authors:  Kaley Boress; Owen J Gaasedelen; Anna Croghan; Marcie King Johnson; Kristen Caraher; Michael R Basso; Douglas M Whiteside
Journal:  Clin Neuropsychol       Date:  2021-02-22       Impact factor: 4.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.